Macquarie Group
NARI

Macquarie Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Macquarie Group’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-55,990
Closed -$2.86M – 1824
2024
Q4 		$2.86M Sell
55,990
-215,251
-79% -$10.6M ﹤0.01% 1084
2024
Q3 		$11.2M Buy
271,241
+214,916
+382% +$10.3M 0.01% 807
2024
Q2 		$2.71M Buy
+56,325
New +$2.5M ﹤0.01% 1133
2024
Q1 		– Sell
-103,900
Closed -$6.75M – 1960
2023
Q4 		$6.75M Buy
103,900
+23,411
+29% +$1.41M 0.01% 902
2023
Q3 		$5.26M Buy
80,489
+60,367
+300% +$3.8M 0.01% 909
2023
Q2 		$1.17M Sell
20,122
-381,971
-95% -$24.1M ﹤0.01% 1331
2023
Q1 		$24.8M Sell
402,093
-1,412,759
-78% -$84.8M 0.03% 610
2022
Q4 		$115M Sell
1,814,852
-713,143
-28% -$51.7M 0.14% 206
2022
Q3 		$184M Sell
2,527,995
-357,735
-12% -$26.6M 0.23% 93
2022
Q2 		$196M Sell
2,885,730
-26,289
-0.9% -$1.89M 0.22% 98
2022
Q1 		$264K Buy
2,912,019
+40,757
+1% +$3.34M 0.2% 90
2021
Q4 		$262M Buy
2,871,262
+164,567
+6% +$14.1M 0.22% 102
2021
Q3 		$220M Buy
2,706,695
+124,730
+5% +$10.5M 0.19% 120
2021
Q2 		$241M Buy
2,581,965
+627,811
+32% +$60.9M 0.2% 107
2021
Q1 		$209M Buy
1,954,154
+1,407,071
+257% +$146M 0.3% 62
2020
Q4 		$47.8M Buy
547,083
+499,525
+1,050% +$35.3M 0.07% 324
2020
Q3 		$3.28M Sell
47,558
-15,688
-25% -$1.01M 0.01% 919
2020
Q2 		$3.06M Buy
+63,246
New +$3.02M 0.01% 898

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $426M AUM 23.62% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Macquarie Group's NARI Position: Q1 2025 in Review

Macquarie Group sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 55,990 shares — an estimated $2.86M sold.

Macquarie Group first reported a position in NARI in Q2 2020 and held it in 18 quarters. The position peaked at $262M in Q4 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Macquarie Group reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Macquarie Group sold 55,990 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $2.86M.
  • Macquarie Group first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 18 quarters.
  • Macquarie Group's Inari Medical, Inc. Common Stock position peaked at $262M in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Macquarie Group's 13F filing for Q1 2025, filed 15 May 2025.